Mersana Therapeutics Inc (NASDAQ: MRSN) Hogging The Spotlight Today
Currently, there are 120.71M common shares owned by the public and among those 90.27M shares have been available to trade. The company’s stock has a 5-day price change of 1.28% and -32.19% over the past three months. MRSN shares are trading -31.90% year to date (YTD), with the 12-month market performance up to 29.51% higher. […]
Growth Story Still Intact For Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc (MRSN) concluded trading on Thursday ata closing price of $1.49, with 3.65 million shares of worth about $5.44 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.69% during that period and on August 15, 2024 the price saw a gain […]
Look For Institutional Buying In Mersana Therapeutics Inc (NASDAQ: MRSN)
Mersana Therapeutics Inc (MRSN) concluded trading on Thursday at a closing price of $1.98, with 2.87 million shares of worth about $5.68 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.74% during that period and on July 25, 2024 the price saw a […]
Mersana Therapeutics Inc (MRSN): Insights At A Glance
Mersana Therapeutics Inc (MRSN) concluded trading on Thursday at a closing price of $3.84, with 4.45 million shares of worth about $17.09 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 225.42% during that period and on Thursday the price saw a gain of […]
Technical Outlook And Game Plan For Mersana Therapeutics Inc (NASDAQ: MRSN)
Mersana Therapeutics Inc (MRSN) concluded trading on Thursday at a closing price of $4.23, with 2.7 million shares of worth about $11.42 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 252.50% during that period and on Thursday the price saw a gain of […]
Do Mersana Therapeutics Inc (NASDAQ: MRSN) Fit In A Value Investing Philosophy?
EcoR1 Capital, LLC recently announced the acquisition of new stake in Mersana Therapeutics Inc (NASDAQ:MRSN). This fresh investment now brings its stake to 16.06% valued currently at $31.95 million. In addition, BlackRock Fund Advisors raised its holdings by 97475.0 to 6.92 million shares. And The Vanguard Group, Inc. has lifted its position by 8.35% or […]
Is Mersana Therapeutics Inc (NASDAQ: MRSN) Proving The Doubters Wrong?
After grabbing 19.36 million shares, the institutional investor is now in possession of 19.36 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 16.07% having worth around $23.04 million. Moreover, BlackRock Fund Advisors increased its share by 97475.0 to have a control over 6.92 million shares. And The […]
